atrial natriuretic peptides (Kalos)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameatrial natriuretic peptides (Kalos)
Drug Alias NameANPs (Kalos)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionMitogen-activated protein kinase inhibitors
TargetsMitogen-activated protein kinase
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKalos Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKalos Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsMacular Degeneration

Other Information

ATC CodeN/A
Related LinksN/A